Anakinra for the inflammatory complications of chronic granulomatous disease

Neth J Med. 2011 Feb;69(2):95.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Comment

MeSH terms

  • Adult
  • Antirheumatic Agents / administration & dosage
  • Antirheumatic Agents / therapeutic use
  • Granulomatous Disease, Chronic / complications
  • Granulomatous Disease, Chronic / drug therapy*
  • Granulomatous Disease, Chronic / immunology
  • Humans
  • Interleukin 1 Receptor Antagonist Protein / administration & dosage
  • Interleukin 1 Receptor Antagonist Protein / therapeutic use*
  • NADPH Oxidases / deficiency*
  • NADPH Oxidases / immunology
  • Reactive Oxygen Species / immunology

Substances

  • Antirheumatic Agents
  • Interleukin 1 Receptor Antagonist Protein
  • Reactive Oxygen Species
  • NADPH Oxidases